Daily non-political popular news in brief.

Cough medicine fights dyskinesias in Parkinson's

11-07-2007 · EurekAlert!

A cough suppressant and a drug tested against schizophrenia curb dyskinesias, the involuntary movements that are disabling side effects of taking the Parkinson's disease medication levodopa, Portland scientists found. Dextromethorphan, used in such cold and flu medications as Robitussin and Sucrets, suppresses dyskinesias in rats. BMY-14802, a drug tested in people with schizophrenia, also suppresses dyskinesias in rats, and does so more effectively than dextromethorphan, suggesting BMY-14802 might block dyskinesias in people with Parkinson's.

Keywords: cough, medicine, fights, dyskinesias, parkinson, fight, dyskinesia

« Previous | Next »

Similar news on "Cough medicine fights dyskinesias in Parkinson's":

Parkinson's Institute research shows that nicotine reduces levodopa-induced dyskinesias
10-24-2007 · EurekAlert!
Research shows that intermittent nicotine treatment reduces medication-induced dyskinesias by as much as 50 percent.
Similar news · Read more »
Transplant drug sirolimus shrinks tumors, improves lung function
01-09-2008 · EurekAlert!
The drug sirolimus, normally used to help transplant patients fight organ rejection, may eventually be used as a less invasive treatment for a tumor called angiomyolipomata in patients with tuberous sclerosis complex or lymphangioleiomyomatosis who would otherwise face surgery. The finding is reported by investigators from Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine in the Jan. 10 edition of the New England Journal of Medicine.
Similar news · Read more »
Parkinson's approach with stem cells a promising first step
12-01-2006 · EurekAlert!
Brain cells derived from human embryonic stem cells improved the condition of rats with Parkinson's-like symptoms dramatically, but the treatment caused a significant problem -- the appearance of brain tumors -- that scientists are now working to solve. The study is featured on the cover of the November issue of Nature Medicine.
Similar news · Read more »
CHPA statement regarding 'Monitoring the Future' findings on cough medicine abuse
12-21-2006 · EurekAlert!
The following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding today's release of the National Institute on Drug Abuse (NIDA)'s Monitoring the Future survey, which includes data on the non-medical use of medicines containing dextromethorphan among 8th, 10th and 12th grade students.
Similar news · Read more »
Researchers led by Penn vet uncover the delicate protein balance behind the immune system response
12-10-2007 · EurekAlert!
A team of researchers from the University of Pennsylvania School of Veterinary Medicine has identified the protein interactions involved in the immune system process that fights infection yet, in certain inflammatory diseases, runs amok and attacks friendly tissue.
Similar news · Read more »
Scientists produce neurons from human skin
02-22-2007 · EurekAlert!
Scientists from Université Laval's Faculty of Medicine have succeeded in producing neurons in vitro using stem cells extracted from adult human skin. This is the first time such an advanced state of nerve cell differentiation has been achieved from human skin, according to lead researcher Professor François Berthod. This breakthrough could eventually lead to revolutionary advances in the treatment of neurodegenerative illnesses such as Parkinson's disease.
Similar news · Read more »
Drugs for Parkinson's disease may ease stroke-related disability
04-10-2007 · EurekAlert!
Scientists have untangled two similar disabilities that often afflict stroke patients, in the process revealing that one may be treatable with drugs for Parkinson's disease. Researchers at Washington University School of Medicine in St. Louis showed that stroke damage in a brain region known as the putamen is strongly linked to motor neglect, a condition that makes patients slow to move toward the left side.
Similar news · Read more »
St. Louis University scientists identify chemical that triggers Parkinson's disease
10-30-2007 · EurekAlert!
Researchers at the St. Louis University School of Medicine have discovered the key brain chemical that causes Parkinson's disease -- a breakthrough finding that could pave the way for new, far more effective therapies to treat one of the most common and debilitating neurological disorders.
Similar news · Read more »
Einstein researchers discover important clue to the cause of Parkinson's disease
01-02-2008 · EurekAlert!
A glitch in the mechanism by which cells recycle damaged components may trigger Parkinson's disease, according to a study by scientists at the Albert Einstein College of Medicine of Yeshiva University. The research, which appears in the Jan. 2 advance online issue of the Journal of Clinical Investigation, could lead to new strategies for treating Parkinson's and other neurodegenerative diseases.
Similar news · Read more »
World AIDS Day: Seeking leadership from the Bush Administration
11-27-2007 · EurekAlert!
This World AIDS Day, the HIV Medicine Association is celebrating the good news from the United Nations Joint Program on HIV/AIDS that the global case count is lower than previous estimates. However, in the United States, this good news is tempered by President Bush's veto of the annual funding bill that provides resources to fight the domestic HIV/AIDS epidemic -- programs that have faced stagnant funding throughout the Bush administration despite the continued growth of the epidemic.
Similar news · Read more »